These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 498165)

  • 41. Fine needle aspiration cytology of prostatic adenocarcinoma metastatic to the lung confirmed by the immunoperoxidase technique.
    Bartziota EV
    Acta Cytol; 1986; 30(5):497-500. PubMed ID: 2430390
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A phase II study of high-dose estrogens (diethylstilbestrol diphosphate) in prostate cancer.
    Citrin DL; Kies MS; Wallemark CB; Khandekar J; Kaplan E; Camacho F; Lind R
    Cancer; 1985 Aug; 56(3):457-60. PubMed ID: 4005808
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Treatment with estramustine phosphate in advanced prostatic cancer].
    Klein D
    Wien Med Wochenschr; 1972 Jul; 122(30):458-60. PubMed ID: 4114990
    [No Abstract]   [Full Text] [Related]  

  • 44. Prostatic acid phosphatase as measured with two radioimmunoassay kits in the detection of prostatic adenocarcinoma.
    Brody JP; Savory J; Sturgill BC; Lehman MR; Wills MR
    Clin Chem; 1981 Apr; 27(4):605-7. PubMed ID: 7471429
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Bone marrow acid phosphatase by radioimmunoassay.
    Belville WD; Cox HD; Mahan DE; Olmert JP; Mittemeyer BT; Bruce AW
    Cancer; 1978 Jun; 41(6):2286-91. PubMed ID: 77719
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Enzyme activity and distribution in the hyperplastic and cancerous human prostate.
    Müntzing J; Nilsson T
    Scand J Urol Nephrol; 1972; 6(2):107-11. PubMed ID: 4114364
    [No Abstract]   [Full Text] [Related]  

  • 47. Immunohistochemical study of androgen receptors in metastatic prostate cancer. Comparison of receptor content and response to hormonal therapy.
    Sadi MV; Walsh PC; Barrack ER
    Cancer; 1991 Jun; 67(12):3057-64. PubMed ID: 1710537
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Immunodiagnosis by prostatic acid phosphatase to differentiate primary male breast cancer from metastatic prostate cancer.
    Kumar PP; Good RR; Newland JR
    J Natl Med Assoc; 1986 Aug; 78(8):782-4, 786. PubMed ID: 3531533
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Immunohistochemical prostatic acid phosphatase level as a prognostic factor of prostatic carcinoma.
    Sakai H; Shiraishi K; Minami Y; Yushita Y; Kanetake H; Saito Y
    Prostate; 1991; 19(3):265-72. PubMed ID: 1946042
    [TBL] [Abstract][Full Text] [Related]  

  • 50. State of the art in immune diagnosis of early adenocarcinoma of the prostate.
    Pontes JE
    Urol Clin North Am; 1980 Oct; 7(3):667-74. PubMed ID: 7456178
    [No Abstract]   [Full Text] [Related]  

  • 51. Carcinoma of prostate metastatic to breast.
    Drelichman A; Amer M; Pontes E; Al-Sarraf M; Vaitkevicius VK
    Urology; 1980 Sep; 16(3):250-5. PubMed ID: 7423701
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Prognostic value of prostatic acid phosphatase in stage B and C prostatic cancer. Apropos of 84 cases].
    Guerin JL; Canal P; Douchez J; Soula G
    Bull Cancer; 1989; 76(10):1077-82. PubMed ID: 2635635
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Breast metastases of prostatic carcinoma: immunohistochemical case study.
    Fukutani K; Kawabe K; Matsuki K; Endo H; Mikata N; Yokoyama M
    Urol Int; 1987; 42(5):395-7. PubMed ID: 2448938
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Considerations for the use of testosterone with systemic chemotherapy in prostatic cancer.
    Fowler JE; Whitmore WF
    Cancer; 1982 Apr; 49(7):1373-7. PubMed ID: 7059952
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Elevated prostatic acid phosphatase: a prognostic factor for stage C adenocarcinoma of the prostate.
    Babaian RJ; Orlando RP
    J Urol; 1986 Nov; 136(5):1035-7. PubMed ID: 3095565
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A critical review of histochemical and electromicroscopical studies of total prostatectomy specimens.
    Kirchheim D
    Prog Clin Biol Res; 1976; 6():357-61. PubMed ID: 1023216
    [No Abstract]   [Full Text] [Related]  

  • 57. [Immunohistochemical diagnosis of a case of metastatic prostate cancer to breast].
    Gotoh A; Matsuura K; Yoshimura S; Takano Y
    Nihon Hinyokika Gakkai Zasshi; 1989 Dec; 80(12):1828-31. PubMed ID: 2483185
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The response of metastatic adenocarcinoma of the prostate to exogenous testosterone.
    Fowler JE; Whitmore WF
    J Urol; 1981 Sep; 126(3):372-5. PubMed ID: 7277602
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [The value of counterimmunoelectrophoresis for the assay of prostatic acid phosphatase].
    Lamy S; Borsi C; Humbel R
    Acta Urol Belg; 1983; 51(3):340-4. PubMed ID: 6624623
    [No Abstract]   [Full Text] [Related]  

  • 60. Prostate cancer metastasis to supraclavicular lymph node.
    Hobdy EM; Shafi NQ; Kummar S
    Clin Adv Hematol Oncol; 2004 Apr; 2(4):223-4; discussion 224. PubMed ID: 16163185
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.